Apimeds Pharmaceuticals US, Inc.

APUS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 17, 2025 PRIMARY DOCUMENT
8-K Oct 16, 2025 CURRENT REPORT
10-Q Aug 19, 2025 QUARTERLY REPORT
NT 10-Q Aug 14, 2025 NOTIFICATION OF LATE FILING
8-K Jul 16, 2025 CURRENT REPORT
4/A Jun 11, 2025 PRIMARY DOCUMENT
3/A Jun 11, 2025 PRIMARY DOCUMENT
8-K Jun 5, 2025 CURRENT REPORT
S-8 May 23, 2025 REGISTRATION STATEMENT
4 May 20, 2025 PRIMARY DOCUMENT
4 May 20, 2025 PRIMARY DOCUMENT
4 May 20, 2025 PRIMARY DOCUMENT
4 May 20, 2025 PRIMARY DOCUMENT
4 May 20, 2025 PRIMARY DOCUMENT
4 May 20, 2025 PRIMARY DOCUMENT
4 May 20, 2025 PRIMARY DOCUMENT
8-K May 20, 2025 CURRENT REPORT
10-Q May 20, 2025 QUARTERLY REPORT
SCHEDULE 13D May 19, 2025
4 May 15, 2025 PRIMARY DOCUMENT
NT 10-Q May 15, 2025 NOTIFICATION OF LATE FILING
4 May 14, 2025 PRIMARY DOCUMENT
4 May 14, 2025 PRIMARY DOCUMENT
3/A May 14, 2025 PRIMARY DOCUMENT
8-K May 12, 2025 CURRENT REPORT
← Newer Page 3 of 6 · 127 filings Older →